ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Electra Therapeutics, Inc.
$8.61−0.14 (-1.60%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
1 of Electra Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 21, 2026 | Sep 21, 2026 | SEC EDGAR |